SCHEMBL6929464

SCHEMBL6929464

Nc1ccc(CCNS(=O)(=O)c2cc(C(=O)Nc3ccc(Br)cc3C(=O)O)cs2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 4/20 0.43
AKR1C1 Q04828 4/20 0.43
AKR1C4 P17516 1/20 0.43
AKR1C3 P42330 1/20 0.43
KCNK2 O95069 1/20 0.40
KCNK10 P57789 1/20 0.40
MAPT P10636 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ABL1 P00519 1/20 0.39
TSHR P16473 1/20 0.39
RIN1 Q13671 1/20 0.39
ALB P02768 1/20 0.38
LTC4S Q16873 1/20 0.38
PPARG P37231 1/20 0.38
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38
PRMT1 Q99873 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6358636 0.85 PRMT1 (0.50) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6357674 0.83 HDAC2 (0.56) AKR1C2AKR1C1AKR1C4AKR1C3MAPT
SCHEMBL6353952 0.81 MEN1 (0.55) AKR1C2AKR1C1AKR1C4AKR1C3MAPT
SCHEMBL6830007 0.79 MEN1 (0.44) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6350735 0.79 F10 (0.51) AKR1C2AKR1C1AKR1C4AKR1C3MAPT
SCHEMBL6834402 0.79 AKR1C2 (0.47) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6834406 0.79 ALDH1A1 (0.44) AKR1C2AKR1C1AKR1C4AKR1C3TDP1
SCHEMBL6349555 0.78 TP53 (0.51) AKR1C3MAPTTDP1MEN1KMT2A
SCHEMBL6833361 0.73 PPARG (0.49) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6830237 0.72 RPA1 (0.47) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 AKR1C2 2596/4885AKR1C1 2161/4885AKR1C4 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.